Screener
Prime Medicine PRME Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $61.14M-9.4% | $77.8M-26.6% | $76.72M-61.0% | $85.09M-35.6% | $67.5M-2.3% | ||
| $47.62M— | $71.39M— | $114.65M— | —— | —— | ||
| $0-100% | $0-100% | —— | -$120K-100% | $120K— | ||
| $96.8M-20.2% | $137.89M-15.8% | $181.29M-14.4% | $231.41M-6.0% | $121.29M-29.0% | ||
| $17.08M-28.3% | $18.82M-24.6% | $20.57M-15.7% | $22.05M-5.3% | $23.83M+0.1% | ||
| $249.04M-10.7% | $294.73M-10.2% | $342.73M+15.2% | $385.01M+15.7% | $279.01M+7.4% | ||
| $5.81M-8.9% | $12.33M+22.9% | $8.89M-21.7% | $9.35M+72.3% | $6.38M+37.5% | ||
| $7.93M-4.6% | $7.32M-10.9% | $7.82M+10.3% | $6.95M-25.1% | $8.32M— | ||
| $31.69M-7.1% | $36.29M+5.8% | $37.45M-1.4% | $35.02M-7.5% | $34.11M+64.4% | ||
| $209.23M-4.1% | $218.03M-1.5% | $221.87M+53.7% | $223.19M+55.8% | $218.15M+246% | ||
| 775M0.0% | 775M0.0% | 775M+38,749,900% | 775M0.0% | 775M0.0% | ||
| -$979.59M-23.7% | -$937.48M-26.8% | -$888.35M-29.3% | -$842.28M-30.6% | -$791.69M-33.6% | ||
| $39.81M-34.6% | $76.7M-28.3% | $120.87M-21.1% | $161.82M-14.6% | $60.86M-69.0% | ||
| $249.04M-10.7% | $294.73M-10.2% | $342.73M+15.2% | $385.01M+15.7% | $279.01M+7.4% |
FAQ
- What are Prime Medicine's total assets?
- Prime Medicine (PRME) holds $249.0M in total assets, down 10.7% year over year.
- How much debt does Prime Medicine have?
- Prime Medicine carries $112.5M in total debt against $39.8M of shareholders' equity, a debt-to-equity ratio of 2.83.
- How much cash does Prime Medicine have?
- Prime Medicine holds $61.1M in cash and equivalents.
- Can Prime Medicine cover its short-term obligations?
- Its current ratio is 3.05 — current assets exceed current liabilities.
- Where does Prime Medicine's balance sheet data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.